fda-psoriasis_drug_50474.jpg - Washington Times

This photo provided by Janssen Biotech, Inc. shows the drug Tremfya. On Thursday, July 13, 2017, the Food and Drug Administration approved the new drug Tremfya, from Johnson &amp; Johnson, for people with moderate to severe plaque psoriasis. (Janssen Biotech, Inc. via AP) — This photo provided by Janssen Biotech, Inc. shows the drug Tremfya. On Thursday, July 13, 2017, the Food and Drug Administration approved the new drug Tremfya, from Johnson & Johnson, for people with moderate to severe plaque psoriasis. (Janssen Biotech, Inc. via AP)

Featured Photo Galleries

Boats return to the Potomac River for plane crash recovery and investigation

Auschwitz memorial holds observances on the 80th anniversary of the death camp's liberation

Trump Inauguration Swearing In

Photo Gallery: Trump returns to the White House

Netanyahu says 'last minute crisis' with Hamas holding up approval of Gaza truce and hostage deal

Israel and Hamas agree to ceasefire deal to pause Gaza war and release some hostages, mediators say

Fire-scarred Los Angeles is under another rare warning as winds pick up

Impeached South Korean President Yoon Suk Yeol taken to detention center

Firefighters brace for strong winds that could fuel Los Angeles fire growth

Jayden Daniels leads Commanders to first playoff win in nearly 7,000 days

Five current and former U.S. presidents gather to honor Jimmy Carter

Firefighters battle to control devastating Los Angeles wildfires